In addition, Tsai et al. and Shen et al. reported that PLOD3 overexpression promotes tumor progression and is associated with a poor prognosis in gliomas and hepatocellular carcinoma (HCC)48,49. Here, PLOD3 is linked to hepatocellular carcinoma.